Further study has demonstrated that in a mouse model of breast cancer, MDSCs secreted IL-6 at the tumor site, thus inducing PSTAT3 expression by tumor cells and promoting tumor progression and metastatic potential (Oh et al., 2013). This evidence concerns the gene IL6 and breast cancer.